Safety and efficacy of triple therapy with Dolutegravir plus 2 NRTIs, in treatment-naive HIV-2 infected patients-48 weeks results from a phase II study

P. Pacheco,N. Marques, P. Rodrigues,K. Mansinho,F. Maltez, N. Janeiro,C. Franco, D. Trigo,J. Batista, L. Duque,M. J. Lopes, M. J. Aleixo,A. R. Silva, R. Tavares,J. Alves,S. Peres,D. Povoas,S. Lino,C. Oliveira,C. Lopes

HIV MEDICINE(2019)

Cited 0|Views29
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined